I think "move fast, and break things" isn't as catchy, when it's harder to ignore that "things" being broken are often people.
I'm not really involved in pharma, but there seems to be a decent argument for selling the drug with provisional approval after safety has been established and collecting outcomes data for those who use provisional drugs https://reason.com/2018/02/02/right-to-try-fda-drug-trials/